A new study published in The Lancet Regional Health found that use of GLP-1 receptor agonists in the context of weight-loss treatment is associated with declines in lean (muscle) mass unless accompanied by targeted strength training interventions
Petrov, A., Perekhvatova, N., Skulachev, M., Stein, L
Since tirzepatide is known to have potent glucose-lowering effects, the present study, published in Diabetologia , sought to clarify the impact of the drug on EWDR across all retinopathy groups
Franke, D
doi: 10.3945/an.116.014506
Heres what users should be aware of: Tesamorelin : The most common side effects include injection site reactions, joint pain, muscle pain, and nausea